SCHEMBL4877329

SCHEMBL4877329

CC(=O)Nc1cccc2c1C(=O)CCCC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.49
ALDH1A1 P00352 5/20 0.48
HPGD P15428 2/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CASP3 P42574 1/20 0.46
BAZ2B Q9UIF8 1/20 0.46
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.43
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
AVPR1A P37288 1/20 0.41
AHR P35869 1/20 0.41
PARP14 Q460N5 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1337358 0.97 BAZ2B (0.49) MAOAALDH1A1HPGDKDM4EGAA
SCHEMBL1612079 0.90 MAOA (0.51) MAOAALDH1A1HPGDKDM4EGAA
SCHEMBL21098726 0.80 NPC1 (0.46) MAOAALDH1A1HPGDKDM4EGAA
SCHEMBL1638724 0.79 ALDH1A1 (0.72) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL18992141 0.78 JAK2 (0.42) MAOAALDH1A1PARP14
SCHEMBL4877265 0.78 ALDH1A1 (0.70) ALDH1A1HPGDKDM4ENPC1RAB9A
SCHEMBL8312077 0.77 CYP2A6 (0.44) MAOAALDH1A1RAB9ABAZ2BMEN1
SCHEMBL22815827 0.77 SMN1; SMN2 (0.43) MAOAALDH1A1HPGDKDM4EGAA
SCHEMBL7655192 0.76 CCNE2 (0.44) MAOAALDH1A1HPGDKDM4EGAA
SCHEMBL30567324 0.76 ALDH1A1 (0.68) ALDH1A1KDM4ENPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735411-B2 Macrocyclic benzofused pyrimidine derivatives ABBVIE INC. (US) 2014-05-27 US disclosed
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives ABBVIE INC. 2008-08-07 US disclosed
US-6407115-B1 ANTICARCINOGENIC AND ANTITUMOR AGENTS; SIDE EFFECT REDUCTION, WATER SOLUBILITY DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-06-18 US disclosed
US-5834476-A DERIVATIVE OF CAMPTOTHECIN, ANTITUMOR AGENT, ANTICARCINOGENIC AGENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-10 US disclosed
US-5770605-A Method for treating leukemia with a hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1998-06-23 US disclosed
US-5658920-A ANTITUMOR AGENTS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-08-19 US disclosed
US-5637770-A Hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-10 US disclosed
EP-0495432-B1 Hexa-cyclic compound DAIICHI SEIYAKU CO (JP) 1996-05-29 EP disclosed
EP-0495432-A1 Hexa-cyclic compound DAIICHI PHARMACEUTICAL CO., LTD. (JP) 1992-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives DPYD, TYMS, UMPS MAOA 1420/4885ALDH1A1 411/4885HPGD 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.